Zhi-Hong Zhu1, Xin Jin2, Yi-Xin Zhang3, Rui Wang1, Tong Wu1, Wei Liu1, Ze-Hua Chen1, Hai-Nan Xie1, Lan-Lan Chen1, Zi-Hao Liu4, Hou-Bin Huang1,2,5. 1. Department of Ophthalmology, Hainan Hospital of Chinese PLA General Hospital, Sanya 572013, Hainan Province, China. 2. Department of Ophthalmology, Chinese PLA General Hospital, Beijing 100853, China. 3. Department of Ophthalmology, the PLA Rocket Force Characteristic Medical Center, Beijing 100088, China. 4. Department of Ophthalmology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China. 5. The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
Abstract
AIM: To describe the clinical heterogeneity of patients with novel mutations in BEST1. METHODS: All the members in the two Chinese families underwent detailed clinical evaluations including best-corrected visual acuity, slit-lamp examination, applanation tonometry, and dilated fundus examination. Fundus autofluorescence, fundus fluorescein angiography, spectral-domain optical coherence tomography, electrooculography, and electroretinogram were also performed. Genomic DNA was extracted from venous blood for all the participants. The targeted next-generation sequencing of inherited retinal disease-associated genes was conducted to identify the causative mutation. RESULTS: A novel BEST1 missense mutation c.41T>C (p.Leu14Ser) was identified in Family 1. It was co-segregated with the phenotype of best vitelliform macular dystrophy (BVMD) and bioinformatics analysis confirmed it was harmful. Another novel BEST1 frameshift mutation c.345_346insGGCAAGGACG (p.Glu119Glyfs*116) and a novel USH2A missense mutation c.12560G>A, p.Arg4187His were identified in family 2 with retinitis pigmentosa (RP), which might interact and lead to the phenotype of RP. CONCLUSION: Two novel mutations in the BEST1 gene in two unrelated families with distinct phenotypes and BEST1 mutation accompanied with USH2A mutation would result in RP, which could be enormously helpful in understanding the pathogenesis of the inherited retinal disease caused by a BEST1 mutation. International Journal of Ophthalmology Press.
AIM: To describe the clinical heterogeneity of patients with novel mutations in BEST1. METHODS: All the members in the two Chinese families underwent detailed clinical evaluations including best-corrected visual acuity, slit-lamp examination, applanation tonometry, and dilated fundus examination. Fundus autofluorescence, fundus fluorescein angiography, spectral-domain optical coherence tomography, electrooculography, and electroretinogram were also performed. Genomic DNA was extracted from venous blood for all the participants. The targeted next-generation sequencing of inherited retinal disease-associated genes was conducted to identify the causative mutation. RESULTS: A novel BEST1 missense mutation c.41T>C (p.Leu14Ser) was identified in Family 1. It was co-segregated with the phenotype of best vitelliform macular dystrophy (BVMD) and bioinformatics analysis confirmed it was harmful. Another novel BEST1 frameshift mutation c.345_346insGGCAAGGACG (p.Glu119Glyfs*116) and a novel USH2A missense mutation c.12560G>A, p.Arg4187His were identified in family 2 with retinitis pigmentosa (RP), which might interact and lead to the phenotype of RP. CONCLUSION: Two novel mutations in the BEST1 gene in two unrelated families with distinct phenotypes and BEST1 mutation accompanied with USH2A mutation would result in RP, which could be enormously helpful in understanding the pathogenesis of the inherited retinal disease caused by a BEST1 mutation. International Journal of Ophthalmology Press.
Authors: Tyler A Pfister; Wadih M Zein; Catherine A Cukras; Hatice N Sen; Ramiro S Maldonado; Laryssa A Huryn; Robert B Hufnagel Journal: Invest Ophthalmol Vis Sci Date: 2021-05-03 Impact factor: 4.799
Authors: Alan D Marmorstein; Tyson R Kinnick; J Brett Stanton; Adiv A Johnson; Ronald M Lynch; Lihua Y Marmorstein Journal: Mol Vis Date: 2015-04-01 Impact factor: 2.367
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Lauren A Dalvin; Jackson E Abou Chehade; John Chiang; Josefine Fuchs; Raymond Iezzi; Alan D Marmorstein Journal: Am J Ophthalmol Case Rep Date: 2016-03-30
Authors: Karina E Guziewicz; Artur V Cideciyan; William A Beltran; András M Komáromy; Valerie L Dufour; Malgorzata Swider; Simone Iwabe; Alexander Sumaroka; Brian T Kendrick; Gordon Ruthel; Vince A Chiodo; Elise Héon; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre Journal: Proc Natl Acad Sci U S A Date: 2018-03-05 Impact factor: 11.205